1. Home
  2. ILMN vs RTO Comparison

ILMN vs RTO Comparison

Compare ILMN & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • RTO
  • Stock Information
  • Founded
  • ILMN 1998
  • RTO 1925
  • Country
  • ILMN United States
  • RTO United Kingdom
  • Employees
  • ILMN N/A
  • RTO N/A
  • Industry
  • ILMN Medical Specialities
  • RTO Business Services
  • Sector
  • ILMN Health Care
  • RTO Consumer Discretionary
  • Exchange
  • ILMN Nasdaq
  • RTO Nasdaq
  • Market Cap
  • ILMN 13.1B
  • RTO 12.2B
  • IPO Year
  • ILMN 2000
  • RTO N/A
  • Fundamental
  • Price
  • ILMN $100.80
  • RTO $24.11
  • Analyst Decision
  • ILMN Buy
  • RTO Hold
  • Analyst Count
  • ILMN 16
  • RTO 1
  • Target Price
  • ILMN $126.88
  • RTO N/A
  • AVG Volume (30 Days)
  • ILMN 2.3M
  • RTO 668.6K
  • Earning Date
  • ILMN 08-05-2025
  • RTO 07-25-2025
  • Dividend Yield
  • ILMN N/A
  • RTO 2.18%
  • EPS Growth
  • ILMN N/A
  • RTO N/A
  • EPS
  • ILMN N/A
  • RTO 0.15
  • Revenue
  • ILMN $4,337,000,000.00
  • RTO $6,805,463,398.00
  • Revenue This Year
  • ILMN N/A
  • RTO $15.25
  • Revenue Next Year
  • ILMN $3.11
  • RTO $4.21
  • P/E Ratio
  • ILMN N/A
  • RTO $31.35
  • Revenue Growth
  • ILMN N/A
  • RTO 1.14
  • 52 Week Low
  • ILMN $68.70
  • RTO $19.60
  • 52 Week High
  • ILMN $156.66
  • RTO $34.07
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 81.33
  • RTO 54.33
  • Support Level
  • ILMN $88.68
  • RTO $23.68
  • Resistance Level
  • ILMN $95.99
  • RTO $24.58
  • Average True Range (ATR)
  • ILMN 2.91
  • RTO 0.34
  • MACD
  • ILMN 0.93
  • RTO 0.03
  • Stochastic Oscillator
  • ILMN 97.37
  • RTO 66.19

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.

Share on Social Networks: